Image Analysis | Tissuepathology.com

Mayo Clinic study shows AI can help clinicians identify brain tumor risks

Erica Goodpaster — Thu, 25 Jun 2026 12:54:00 +0000

ROCHESTER, Minn. — Mayo Clinic researchers and collaborators have shown that an artificial intelligence (AI) tool can analyze routine pathology slides to help clinicians classify meningiomas, the most common primary brain tumor in adults, and better understand a patient’s risk of tumor recurrence. The study, published in The Lancet Digital Health, demonstrates that deep learning models can support the extraction of […]

The post Mayo Clinic study shows AI can help clinicians identify brain tumor risks first appeared on Tissuepathology.com.

Versant Diagnostics Expands Collaboration with Leica Biosystems as PRW Laboratories Becomes First to Deploy Aperio GT Elite Solution

Erica Goodpaster — Wed, 24 Jun 2026 13:08:58 +0000

Versant Diagnostics and Leica Biosystems: Milestone deployment reflects growing demand for high-throughput, AI-enabled digital pathology workflows VISTA, CA, June 24, 2026 – Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, and Versant Diagnostics, an independent physician services company actively engaged in next-generation digital pathology, announce an expanded collaboration […]

The post Versant Diagnostics Expands Collaboration with Leica Biosystems as PRW Laboratories Becomes First to Deploy Aperio GT Elite Solution first appeared on Tissuepathology.com.

Spotlight Medical Secures IVDR CE Marking for myStage Dx, Its AI-Enabled Prognostic Test for ER+/HER2 – Early Breast Cancer

Erica Goodpaster — Tue, 23 Jun 2026 13:17:57 +0000

Spotlight Medical: Class C software-only IVD supports European rollout of a JCO-published assay designed to bring clinically validated prognostic assessment into routine breast cancer care. PARIS–(BUSINESS WIRE)–Spotlight Medical, a Paris-based oncology diagnostics company, today announced that myStage Dx has received CE marking under the European Union In Vitro Diagnostic Medical Devices Regulation (IVDR, Regulation (EU) […]

The post Spotlight Medical Secures IVDR CE Marking for myStage Dx, Its AI-Enabled Prognostic Test for ER+/HER2 – Early Breast Cancer first appeared on Tissuepathology.com.

Tribun Health: The Time to Go Digital Is Now… and It’s More Achievable Than You Think

Erica Goodpaster — Mon, 22 Jun 2026 15:04:23 +0000

From the Tribun Health blog: Discover why digital pathology adoption is accelerating and how laboratories can transition progressively toward scalable digital diagnosis. For several years now, digital pathology has been presented as the new way to practice pathology. The difference today is that this future has become reality, and laboratories making the transition are discovering that the […]

The post Tribun Health: The Time to Go Digital Is Now… and It’s More Achievable Than You Think first appeared on Tissuepathology.com.

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Erica Goodpaster — Fri, 19 Jun 2026 12:16:28 +0000

Charles River and Lilly Tune Lab: Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) announced a collaboration with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). TuneLab was created to […]

The post Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise first appeared on Tissuepathology.com.

Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists

Erica Goodpaster — Thu, 18 Jun 2026 15:22:57 +0000

PHILADELPHIA — June 17, 2026 — Proscia® today introduced the Fifth Generation of its Concentriq®[1] platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to evidence-based program decisions. Proscia is trusted by diagnostic laboratories that manage 12 million patient cases annually, and 16 of the top 20 pharmaceutical companies. Pathology sits […]

The post Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists first appeared on Tissuepathology.com.